Abstract:Despite exciting advances in structural intravascular imaging [intravascular ultrasound (IVUS) and optical coherence tomography (OCT)] that have enabled partial assessment of atheroma burden and high-risk features associated with acute coronary syndromes, structural-based imaging modalities alone do not comprehensively phenotype the complex pathobiology of atherosclerosis. Near-infrared fluorescence (NIRF) is an emerging molecular intravascular imaging modality that allows for in vivo visualization of pathobiological and cellular processes at atheroma plaque level, including inflammation, oxidative stress, and abnormal endothelial permeability. Established intravascular NIRF imaging targets include macrophages, cathepsin protease activity, oxidized low-density lipoprotein and abnormal endothelial permeability. Structural and molecular intravascular imaging provide complementary information about plaque microstructure and biology. For this reason, integrated hybrid catheters that combine NIRF-IVUS or NIRF-OCT have been developed to allow co-registration of morphological and molecular processes with a single pullback, as performed for standalone IVUS or OCT. NIRF imaging is approaching application in clinical practice. This will be accelerated by the use of FDA-approved indocyanine green (ICG), which illuminates lipid- and macrophage-rich zones of permeable atheroma. The ability to comprehensively phenotype coronary pathobiology in patients will enable a deeper understanding of plaque pathobiology, improve local and patient-based risk prediction, and usher in a new era of personalized therapy.

Exogenous imaging contrast and therapeutic agents for intravascular photoacoustic imaging and image-guided therapy

Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents

Functional Imaging of Cerebrovascular Activities in Small Animals Using High-Resolution Photoacoustic Tomography.

Intravascular MR Imaging and Intravascular MR-guided Interventions.

Therapeutic and Contrast Agents for Photoacoustic Imaging-Guided Photothermal Therapy: A Narrative Review

Exogenous Contrast Agents in Photoacoustic Imaging: An In Vivo Review for Tumor Imaging

Intravascular Photoacoustic Imaging at 35 and 80 MHz

Photoacoustic Imaging: Contrast Agents and Their Biomedical Applications

A review of clinical photoacoustic imaging: Current and future trends

Integrated Intravascular Ultrasound and Optical-Resolution Photoacoustic Microscopy with A 1-Mm-diameter Catheter

Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology

Intravascular Optical-Resolution Photoacoustic Tomography with a 1.1 Mm Diameter Catheter.

Intravascular Molecular Imaging: Near-Infrared Fluorescence as a New Frontier

Contrast Agents for Photoacoustic Imaging: A Review Focusing on the Wavelength Range

High Frequency Intravascular Photoacoustic (Ivpa) Imaging For Differentiating Arterial Wall Layered Structures

Recent Advances in Contrast-Enhanced Photoacoustic Imaging: Overcoming the Physical and Practical Challenges.

Advances in photoacoustic imaging aided by nano contrast agents: special focus on role of lymphatic system imaging for cancer theranostics

Spectroscopic Intravascular Photoacoustic Imaging of Lipids in Atherosclerosis

Combined intravascular photoacoustic and ultrasound imaging imaging of atherosclerotic calcification in human artery

High-Speed Intravascular Spectroscopic Photoacoustic Imaging at 1000 A-Lines Per Second with A 0.9-Mm Diameter Catheter

Phthalocyanine-based Photoacoustic Contrast Agents for Imaging and Theranostics